  Over the past few decades, researchers have developed several approaches such
as the Reference Phantom Method (RPM) to estimate ultrasound attenuation
coefficient (AC) and backscatter coefficient (BSC). AC and BSC can help to
discriminate pathology from normal tissue during in-vivo imaging. In this
paper, we propose a new RPM model to simultaneously compute AC and BSC for
harmonic imaging and a normalized score that combines the two parameters as a
measure of disease progression. The model utilizes the spectral difference
between two regions of interest, the first, a proximal, close to the probe and
second, a distal, away from the probe. We have implemented an algorithm based
on the model and shown that it provides accurate and stable estimates to within
5% of AC and BSC for simulated received echo from post-focal depths of a
homogeneous liver-like medium. For practical applications with time gain and
time frequency compensated in-phase and quadrature (IQ) data from ultrasound
scanner, the method has been approximated and generalized to estimate AC and
BSC for tissue layer underlying a more attenuative subcutaneous layer. The
angular spectrum approach for ultrasound propagation in biological tissue is
employed as a virtual Reference Phantom (VRP). The VRP is calibrated with a
fixed probe and scanning protocol for application to liver tissue. In a
feasibility study with 16 subjects, the method is able to separate 9/11 cases
of progressive non-alcoholic fatty liver disease from 5 normal. In particular,
it is able to separate 4/5 cases of non-alcoholic steato-hepatitis and early
fibrosis (F<=2) from normal tissue. More extensive clinical studies are needed
to assess the full capability of this model for screening and monitoring
disease progression in liver and other tissues.
